[HTML][HTML] Management guidelines for children with thyroid nodules and differentiated thyroid cancer
L FrancisGary, G WaguespackSteven, J BauerAndrew… - Thyroid, 2015 - liebertpub.com
Background: Previous guidelines for the management of thyroid nodules and cancers were
geared toward adults. Compared with thyroid neoplasms in adults, however, those in the …
geared toward adults. Compared with thyroid neoplasms in adults, however, those in the …
2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …
BR Haugen, EK Alexander, KC Bible, GM Doherty… - Thyroid, 2016 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor-and PSMA-targeting ligands
K Sjögreen Gleisner, N Chouin, PM Gabina… - European journal of …, 2022 - Springer
The purpose of the EANM Dosimetry Committee is to provide recommendations and
guidance to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals …
guidance to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals …
Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with …
J Violet, P Jackson, J Ferdinandus… - Journal of Nuclear …, 2019 - Soc Nuclear Med
177Lu-prostate-specific membrane antigen (PSMA)–617 enables targeted delivery of β-
particle radiation to prostate cancer. We determined its radiation dosimetry and relationships …
particle radiation to prostate cancer. We determined its radiation dosimetry and relationships …
[PDF][PDF] SNMMI procedure standard/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version
AM Avram, L Giovanella, B Greenspan, SA Lawson… - 2022 - Soc Nuclear Med
Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …
new standards/guidelines for nuclear medicine practice to help advance the science of …
Guidelines for radioiodine therapy of differentiated thyroid cancer
M Luster, SE Clarke, M Dietlein, M Lassmann… - European journal of …, 2008 - Springer
Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …
European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer …
M Luster, C Aktolun, I Amendoeira, M Barczyński… - Thyroid, 2019 - liebertpub.com
Background: The American Thyroid Association (ATA) management guidelines for patients
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …
The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0
EB Silberstein, A Alavi, HR Balon… - Journal of Nuclear …, 2012 - Soc Nuclear Med
THERAPY OF THYROID DISEASE WITH 131I• Silberstein et al. 1633 patients throughout
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …
Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome
SJ Bonnema, L Hegedüs - Endocrine reviews, 2012 - academic.oup.com
Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …
patients treated since then are probably numbered in the millions. Fifty to 90% of …
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
M Konijnenberg, K Herrmann, C Kobe… - European journal of …, 2021 - Springer
Executive Summary The EC Directive 2013/59/Euratom states in article 56 that exposures of
target volumes in nuclear medicine treatments shall be individually planned and their …
target volumes in nuclear medicine treatments shall be individually planned and their …